Immediate injection pain in infants aged 18 months during vaccination against measles, mumps and rubella with either Priorix® or MMR-II®

Vaccine

Volumn 24, Issue 31-32, 2006, Pages 5800-5805

  Knutsson, Nina ^a   Jansson, Ulla Britt ^b   Alm, Bernt ^b  

^a Research and Development Unit in Primary Health Care   (Sweden)

^b QUEEN SILVIA CHILDREN'S HOSPITAL   (Sweden)

Author keywords

Infants; MMR; Pain; Vaccination

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE; MMR II;

AGE DISTRIBUTION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HEALTH PRACTITIONER; HUMAN; INJECTION PAIN; MAJOR CLINICAL STUDY; MALE; MEASLES; MUMPS; PAIN ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RUBELLA; VACCINATION; VISUAL ANALOG SCALE;

CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INFANT; INJECTIONS, INTRAMUSCULAR; MALE; MEASLES; MEASLES-MUMPS-RUBELLA VACCINE; MUMPS; PAIN; PAIN MEASUREMENT; RUBELLA; VACCINATION;

EID: 33745640266     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.05.004     Document Type: Article

References (23)

1. Gothefors L., Bergström E., and Backman M. Immunogenicity and reactogenicity of a new measles, mumps and rubella vaccine when administered as a second dose at 12 y of age. Scand J Infect Dis 33 7 (2001) 545-549
2. Usonis V., Bakasenas V., Kaufhold A., Chitour K., and Clemens R. Reactogenicity and immunogenicity of a new live attenuated combined measles, mumps and rubella vaccine in healthy children. Pediatr Infect Dis J 18 (1999) 42-48
3. Lee C.-Y., Tang R.-B., Huang F.-Y., Tang H., Huang L.-M., and Bock H.L. A new measles, mumps, rubella (MMR) vaccine: a randomised comparative trial for assessing the reactogenicity and immunogenicity of three consecutive production lots and comparison with a widely used MMR vaccine in measles primed children. Int J Infect Dis 6 (2002) 202-207
4. SoS. Childhood vaccination programme. SoSFS (M) 1996:1.
5. Halperin S.A., McGrath P., Smith B., and Houston T. Lidocain-prilocain patch decreases the pain associated with the subcutaneous administration of measles-mumps-rubella vaccine but does not adversely affect the antibody response. J Pediatr 136 6 (2000) 789-794
6. Leask J., and McIntyre P. Public opponents of vaccination: a case study. Vaccine 21 (2003) 4700-4703
7. De Melker H., Pebody R.G., Edmunds W.J., Lévy-Bruhl D., Valle M., Rota M.C., et al. The seroepidemiology of measles in Western Europé. Epidemiol Infect 126 2 (2001) 249-259
8. Jacobson R.M., et al. Making vaccines more acceptable-methods to prevent and minimize pain and other common adverse events associated with vaccines. Vaccine 19 17-19 (2001) 2418-2427
9. Clements C.J., Evans G., Dittman S., and Reeler A.V. Vaccine safety concerns everyone. Vaccine 17 (1999) 90-94
10. WHO. Six common misconceptions concerning vaccines. From homepage: http://www.who.mtgpv-safety, WHO, 1998.
11. Dittmann S. Vaccine safety: risk communication a global perspective. Vaccine 19 (2001) 2446-2456
12. Jefferson T., Price D., Demicheli V., Bianco E., and The European Research Program for Improved Vaccine Safety Surveillance (EUSAFEVAC) Project. Unintended events following immunisation with MMR: a systematic review. Vaccine 21 (2003) 3954-3960
13. Heijbel H., and Jefferson T. Vaccine safety-improving monitoring. Vaccine 19 (2001) 2457-2460
14. McGrath P. Evaluating a child's pain. J Pain Symptom Manage 4 (1989) 198-214
15. Stein P.R. Indices of pain intensity: construct validity among preschoolers. Pediatr Nurs 2 (1995) 119-123
16. McGrath P.J., Johnson G., Goodman J.T., Schillinger J., Dunn J., and Chapman J.-A. CHEOPS: a behavioural scale for rating pain in children, advance in pain research and therapy vol 9 (1985), Raven Press, New York
17. Kazdin A.E. Assessing the clinical or applied importance of behaviour change through social validation. Behav Modif 1 (1977) 427-449
18. Bijur P.E., Silver W., and Gallagher E.J. Reliability of the visual analog scale for measurement of acute pain. Acad Emerg Med 12 (2001) 1153-1157
19. Norusis M. SPSS for Windows. Advanced statistics. Release 6.0 (1993), SPSS Inc., Chicago
20. Moher D., Schultz K.F., and Altman D.G. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 357 (2001) 1191-1194
21. Lyons R., and Howell F. Pain and measles, mumps and rubella vaccination. Arch Dis Child 66 (1991) 346-347
22. Ipp M., Cohen E., Goldbach M., and Macarthur C. Effect of choice of measles-mumps-rubella vaccine on immediate vaccination pain in infants. Arch Pediatr Adolesc Med 158 (2004) 323-326
23. Wood C., Von Baeyer C.L., Bourrillon A., Dejos-Conant V., Clyti N., and Abitol V. Self-assessment of immediate post-vaccination pain after two different MMR vaccines administered as a second dose in 4- to 6-year-old children. Vaccine 23 (2004) 127-131